Skip to main content
Have a personal or library account? Click to login
Prolonged QT Interval in Hospitalized Internal Medicine Patients: A Retrospective Cohort Study of Determinants and Reversibility Cover

Prolonged QT Interval in Hospitalized Internal Medicine Patients: A Retrospective Cohort Study of Determinants and Reversibility

Open Access
|Oct 2026

References

  1. SEMSARIAN C., INGLES J., WILDE A.M. Sudden cardiac death in the young: the molecular autopsy and a practical approach to surviving relatives. Eur Heart J. 2015;36(21):1290–1296.
  2. KAHLON S.S., SIKANDAR R., TEJOVATH S., et al. Diagnosing torsades de pointes based on correlation to QT interval: a systematic review. Cureus. 2022;14(8):e28114.
  3. SCHWARTZ P.J., MOSS A.J., VINCENT G.M., CRAMPTON R.S. Diagnostic criteria for the long QT syndrome: an update. Circulation. 1993;88(2):782–784.
  4. VANDAEL E., VANDENBERK B., VANDENBERGHE J., WILLEMS R., FOULON V. Risk factors for QTc-prolongation: systematic review of the evidence. Int J Clin Pharm. 2017;39(1):16–25.
  5. BAZETT H.C. An analysis of the time-relations of electrocardiograms. Ann Noninvasive Electrocardiol. 1997;2(2):177–194.
  6. SAGIE A., LARSON M.G., GOLDBERG R.J., BENGTSON J.R., LEVY D. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am J Cardiol. 1992;70(7):797–801.
  7. PASQUIER M., PANTET O., HUGLI O., et al. Prevalence and determinants of QT interval prolongation in medical inpatients. Intern Med J. 2012;42(8):933–940.
  8. ROSSI M., MARZI F., NATALE M., et al. Drug-associated QTc prolongation in geriatric hospitalized patients: a cross-sectional study in internal medicine. Drugs Real World Outcomes. 2021;8(3):325–335.
  9. RAUTAHARJU P.M., SURAWICZ B., GETTES L.S., et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV. J Am Coll Cardiol. 2009;53(11):982–991.
  10. CredibleMeds. QTDrugs lists [Internet]. 2013 [cited 2024 Nov 20]. Available from: https://www.crediblemeds.org/
  11. VANDENBERK B., VANDAEL E., ROBYNS T., et al. Which QT correction formulae to use for QT monitoring? J Am Heart Assoc. 2016;5(6):e003264.
  12. RABKIN S.W., CHENG X.J., THOMPSON D.S. Detailed analysis of the impact of age on the QT interval. J Geriatr Cardiol. 2016;13(9):740–748.
  13. PFEIFER M.A., WEINBERG C.R., COOK D., BEST J.D., REENAN A., HALTER J.B. Differential changes of autonomic nervous system function with age in man. Am J Med. 1983;75(2):249–258.
  14. COLIVICCHI F., BASSI A., SANTINI M., CALTAGIRONE C. Prognostic implications of right-sided insular damage, cardiac autonomic derangement, and arrhythmias after acute ischemic stroke. Stroke. 2005;36(8):1710–1715.
  15. WU J., NIZHAMUDING D., LIU P., et al. QT interval prolongation in patients with acute ischemic stroke. J Int Med Res. 2019;47(12):5986–5995.
  16. NISHIYAMA T., KONDO Y., TSUBOI H., et al. QTc interval prolongation in patients with systemic lupus erythematosus treated with hydroxychloroquine. Mod Rheumatol. 2021;31(6):1107–1112.
  17. VILLA ZAPATA L., BOYCE R.D., CHOU E., et al. QTc prolongation with the use of hydroxychloroquine and concomitant arrhythmogenic medications. Drugs Real World Outcomes. 2022;9(3):415–423.
  18. HREICHE R., TURGEON J. Interactions médicamenteuses et risque de torsades de pointes. Pharmactuel. 2005;38(3):134–139.
  19. TANG J.K., RABKIN S.W. Hypocalcemia-induced QT interval prolongation. Cardiology. 2022;147(2):191–195.
  20. SHIMAOKA T., WANG Y., MORISHIMA M., MIYAMOTO S., ONO K. Magnesium deficiency causes transcriptional downregulation of Kir2.1 and Kv4.2 channels in cardiomyocytes resulting in QT interval prolongation. Circ J. 2020;84(8):1244–1253.
  21. DI IORIO B., TORRACA S., PISCOPO C., et al. Dialysate bath and QTc interval in patients on chronic maintenance hemodialysis: pilot study of single dialysis effects. J Nephrol. 2012;25(5):653–660.
  22. EMMETT M. Metabolic alkalosis: a brief pathophysiologic review. Clin J Am Soc Nephrol. 2020;15(12):1848–1856.
  23. NINKOVIC V.M., NINKOVIC S.M., MILORADOVIC V., et al. Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes. Acta Diabetol. 2016;53(5):737–744.
  24. KOBAYASHI S., NAGAO M., ASAI A., et al. Severity and multiplicity of microvascular complications are associated with QT interval prolongation in patients with type 2 diabetes. J Diabetes Investig. 2018;9(4):946–951.
DOI: https://doi.org/10.2478/rjim-2026-0023 | Journal eISSN: 2501-062X (formerly 1220-4749) | Journal ISSN: 1220-4749
Language: English, Romanian
Submitted on: Jun 10, 2026
Published on: Oct 22, 2026
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services

© 2026 Donia Chebbi, Wiem Bougarn, Fedy Mtar, Fatma Ben Dahmen, Meya Abdallah, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.